Richard Gruenewald works in the field of Oncology. He attended University of Missouri-Columbia School of Medicine. Richard L. Gruenewald is also a published doctor. He has 15 paper published. The most recent paper is: Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes. He accepts all Medicare patients.
University of Missouri-Columbia
University of Missouri-Columbia School of Medicine| NPI NUMBER | 1184671166 | |
| NPPES Provider LastName | GRUENEWALD | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 423031785 | |
| NPPES Provider State | KY | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 99.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
| National Provider Identifier [NPI] | 1184671166 |
| Last Name Of The Provider | GRUENEWALD |
| First Name Of The Provider | RICHARD |
| View All |
|
Dr. Dattatraya S. Prajapati, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John R. Eckardt, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Mohammed A. Sayed, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James R. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jewraj G. Maheshwari, MD
This Doctor is OpenDoctor Recommended.
|